Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants

Vaccine

Volumn 15, Issue 9, 1997, Pages 1039-1044

  Benne, C A ^a,b   Harmsen, M ^b   Van Der Graaff, W ^b   Verheul, A F M ^b   Snippe, H ^b   Kraaijeveld, C A ^b  

^a Public Health Service of Groningen   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adjuvants; Influenza A virus; Subunit vaccine; Virus neutralizing antibodies

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; SAPONIN; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; IMMUNIZATION; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BINDING, COMPETITIVE; CELLS, CULTURED; FEMALE; HAPLORHINI; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INFLUENZA A VIRUS; INFLUENZA VACCINES; KIDNEY; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 0031171901     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00287-3     Document Type: Article

References (34)

1. 1 Ada, G.L. and Jones, P.D. The immune response to influenza virus infection [review]. Curr. Top Microbiol. Immunol. 1986, 128, 1-54
2. 2 Couch, R.B. and Kasel, J.A. Immunity to influenza in man. A. Rev. Microbiol. 1983, 37, 529-549
3. 3 Possee, R.D., Schild, G.C. and Dimmock, N.J. Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity. J. Gen. Virol. 1982, 58, 373-386
4. 4 Grey, H.M., Hirst, J. and Cohn, M. A new mouse immunoglobulin: IgGS. J. Exp. Med. 1971, 133, 289-304
5. 5 Burton, D.R. Review: immunoglobulin G functional sites. Molec. Immunol. 1985, 22, 161-206
6. 6 Neuberger, M.S. and Rajewsky, K. Activation of mouse complement by monoclonal mouse antibodies. Eur. J. Immunol. 1981, 11, 1012-1016
7. 7 Coutelier, J.P., van der Logt, J.T.M., Heesssen, F.W.A., Warnier, G. and van Snick, J. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 1987, 165, 64-69
8. 8 Hocart, M.J., Mackenzie, J.S. and Stewart, G.A. The immunoglobulin G subclass response of mice to influenza A virus: the effect of mouse strain, and the neutralizing abilities of individual protein A-purified subclass antibodies. J. Gen. Virol. 1989, 70, 2439-2448
9. 9 Hocart, M.J., Mackenzie, J.S. and Stewart, G.A. The IgG subclass responses to influenza virus haemagglutinin in the mouse: effect of route of inoculation. J. Gen. Virol. 1989, 70, 809-818
10. 5. 1. Effects of carrier, copolymer, adjuvants and lipopolysaccharide on isotype selection. J. Immunol. 1990, 146, 3583-3590
11. 11 Karagouni, E.E. and Hadjipetrou-Kourounakis, L. Regulation of isotype immunoglobulin production by adjuvants in vivo. Scand. J. Immunol. 1990, 31, 745-754
12. 12 Kenney, J.S., Hughes, B.W., Massada, M.P. and Allison, A.C. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J. Immunol. Meth. 1989, 121, 157-166
13. 13 Benne, C.A., Harmsen, M., de Jong, J.C. and Kraaijeveld, C.A. Neutralization enzyme immunoassay for influenza virus. J. Clin. Microbiol. 1994, 32, 987-990
14. 14 Kensil, C.R., Patel, U., Lennick, M. and Marciani, D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina Cortex J. Immunol. 1991, 146, 431-437
15. 15 Barteling, S.J. and Vreeswijk, J. Developments in foot-and-mouth disease vaccines. Vaccine 1991, 9, 75-88
16. 16 Dalsgaard, K. Adjuvants. Vet. Immunol. Immunopathol. 1987, 17, 145-152
17. 17 Hunter, R., Olsen, M. and Buynitzky, S. Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titer and isotype of antibody. Vaccine 1991, 9, 250-265
18. 18 Harder, T.C., Klusmeyer, K , Frey, H.-R., Örvall, C. and Liess, B. Intertypic differentiation of intratypic variants amoung canine and phocid morbilli virus by kinetic neutralization using a novel immunoplaque assay. J. Virol. Meth. 1993, 41, 77-92
19. 19 Nakane, P.R. and Kawaoi, A. Peroxidase labeled antibody: a new method of conjugation. J. Histochem. Cytochem. 1974, 22, 1084-1091
20. 20 Armitage, P. and Berry, G. Statistical Methods In Medical Research, 2nd edn. Blackwell Scientific Publications, 1987, pp. 186-193, pp. 417-419
21. 21 Hunter, R.L., Strickland, F. and Kédzy, F. Studies on the adjuvant activity of non-ionic block copolymer surfactants. I. The role of hydrophil-lipophil balance. J. Immunol. 1981, 127, 293-306
22. 22 Takayama, K., Olsen, M., Datta, P. and Hunter, R.L. Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors. Vaccine 1991, 9, 257-265
23. 23 Allison, A.C. and Byars, N.E. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and cell-mediated immunity J. Immunol. Meth. 1986, 95, 157-168
24. 24 Zigterman, J.G.W.J., Schotanus, K. and Ernste, E.B.H.W. et al. Nonionic block polymer surfactants modulate the humoral immune response against Streptococcus pneumoniae-derived hexasaccharide-protein conjugates. Infect. Immun. 1989, 57, 2712-2718
25. 25 Allison, A.C. and Byars, N.E. Immunological adjuvants: desirable properties and side effects. Molec. Immunol. 1991, 28, 279-284
26. 26 Hadjipetrou-Kourounakis, L. and Möller, E. Adjuvants influence the immunoglobulin subclass distribution of immune responses in vivo. Scand. J. Immunol. 1984, 19, 219-225
27. 27 Fernández, I.M., Snijders, A., Benaissa-Trouw, B.J., Harmsen, M., Snippe, H. and Kraaijeveld, C.A. Influence of epitope polarity and adjuvants on the immunogenicity of a synthetic peptide vaccine against Semliki Forest virus. J. Virol. 1993, 67, 5843-5848
28. 28 Verheul, A.F.M., Van Gaans, J.A.M., Wiertz, E.J.H., Snippe, H., Verhoef, J. and Poolman, J.T. Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein-but not LPS-specific bactericidal antibodies in mice: influence of adjuvants. Infect. Immun. 1993, 61, 187-196
29. 29 Powers, D.C. Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine. J. Med. Virol. 1994, 43, 57-61
30. 30 Remarque, E.J., van Beek, W.C.A. and Ligthart, G.J. et al. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines. Vaccine 1993, 11, 649-654
31. 31 D'Alessio, D.J., Cox Jr, P.M. and Dick, E.C. Failure of inactivated influenza vaccine to protect an aged population. J. Am. Med. Assoc. 1969, 210, 485-489
32. 32 Feery, B.J., Evered, M.G. and Morrison, E.I. Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. J. Infect. Dis. 1979, 139, 237-241
33. 33 Strassburg, M.A., Greenland, S., Sorvillo, F.J., Lieb, L.E. and Habel, L.A. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986, 4, 38-44
34. 34 Gupta, R.K., Relyveld, E.H., Lindblad, E.B., Bizzini, B., Ben-Efraim, S. and Gupta, K.G. Adjuvants - a balance between toxicity and adjuvanticity. [Review]. Vaccine 1993, 11, 293-306